Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Data concerning the clinical impact of combination therapy with β-blockers (BBs) + angiotensin-converting enzyme inhibitors (ACEIs) compared with BBs + angiotensin-receptor blockers (ARBs) in patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) are limited.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am J Cardiovasc Drugs

Title: American journal of cardiovascular drugs : drugs, devices, and other interventions

Publisher: Springer Science and Business Media LLC

ISSN (Electronic): 1179-187X

ISSN (Print): 1175-3277

Publication date (Electronic): Aug 2019

Volume: 19

Issue: 4

Affiliations

[1 ] Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, 156 Baengnyeong Road, Chuncheon, Gangwon Province, 24289, South Korea. yhkim02@kangwon.ac.kr.

[2 ] Division of Cardiology, Department of Internal Medicine, Kangwon National University School of Medicine, 156 Baengnyeong Road, Chuncheon, Gangwon Province, 24289, South Korea.

[3 ] Department of Cardiology, Chonnam National University Hospital, Gwangju, South Korea.

[4 ] Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea.

Article

Publisher Item ID: 10.1007/s40256-019-00326-8

DOI: 10.1007/s40256-019-00326-8

PubMed ID: 30788675

SO-VID: 2bfd16fe-362e-4258-9b9d-c43f14807d34

History

Data availability:

Comments

Comment on this article

scite_

Cited by 4

See all cited by